ダウンロード数: 128
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
25_0969.pdf | 468.65 kB | Adobe PDF | 見る/開く |
タイトル: | Gestenorone capronate(Depostat)による前立腺肥大症の治療 |
その他のタイトル: | TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH GESTENORONE CAPRONATE |
著者: | 田中, 求平 梶尾, 克彦 平山, 多秋 田戸, 治 溝口, 勝 白石, 恒雄 |
著者名の別形: | Tanaka, Kyuhei Kajio, Katsuhiko Hirayama, Masaaki Tado, Osamu Mizoguchi, Masaru Shiraishi, Tsuneo |
発行日: | Sep-1979 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 25 |
号: | 9 |
開始ページ: | 969 |
終了ページ: | 976 |
抄録: | l7-hydroxy-19-norprogesterone caproate (Depostat) was administered to a total of 24 patients (average age of 69.2) comprising 20 patients with stage II of prostatic hypertrophy and 4 patients with stage III. Depostat was injected in all patients into the gluteal muscle at a dosage of 200 mg once every week for 12 weeks (12 times) consecutively (total dosage of 2, 400 mg). 1) Subjective symptoms were alleviated in 54% of the patients. Especially, the alleviation was observed in 65% of the patients with stage II of prostatic hypertrophy. 2) The decreases in the frequency of urination/day and in residual urinary volume were observed in 75% and 60% of the patients respectively. These decreases were significant in a statistical analysis. 3) The decrease observed in the prostatic weight which was measured by Thumann's method was significant in a statistical analysis. 4) There were no serious side effects. However, mild fever was observed in 2 cases and there was significant decrease of hematocrit value in a statistical analysis, but the changes were within the normal range. |
URI: | http://hdl.handle.net/2433/122493 |
出現コレクション: | Vol.25 No.9 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。